ÂÜÀòÂÒÂ×

Markus Imboden is an experienced financial executive currently serving as CFO at Oetiker Group since November 1998, overseeing finance, controlling, and treasury functions while managing teams in Switzerland and abroad. Previous roles include Corporate Controller and Assistant to the CEO at Endogena Therapeutics AG from October 2020 to June 2022, and various positions at Rega from June 1992 to October 1998, including Assistant to Management and Development Engineer/Project Manager. Markus Imboden holds multiple degrees, including an Executive MBA from the University of Zurich, a CAS in Swiss Certified Treasury from Lucerne University of Applied Sciences and Arts, and several qualifications in accounting and engineering from various institutions.